QuidelOrtho Corporation (QDEL) News
Track canonical SquawkNews coverage tagged to QDEL, QuidelOrtho Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Faster Answers, Better Decisions: ADLM 2026 Highlights
Faster Answers, Better Decisions: ADLM 2026 Highlights
EQUITY | Aug 27, 2026, 01:12 PM UTC
L
QDEL - Faster Answers, Better Decisions: ADLM 2026 Highlights
QDEL - Faster Answers, Better Decisions: ADLM 2026 Highlights
EQUITY | Aug 27, 2026, 01:12 PM UTC
H
Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 300 points on Friday. The Dow traded up 0.30% to 54,048.67 while the NASDAQ rose 1.20% to 26,663.54. The S&P 500 also rose,
EARNINGS | Aug 07, 2026, 07:19 PM UTC
H
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq 100 futures gaining over 100 points on Friday. Shares of Trade Desk Inc (NASDAQ: TTD ) fell sharply in pre-market trading after the company reported worse-than-
EARNINGS | Aug 07, 2026, 12:02 PM UTC
H
Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket
Shares of Atlassian Corp (NASDAQ: TEAM ) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results. Atlassian reported fourth-quarter revenue of $1.766 billion, u
EARNINGS | Aug 07, 2026, 08:33 AM UTC
L
QuidelOrtho Lowers FY2026 Adj EPS Guidance from $1.80-$2.00 to $0.65-$0.90 vs $1.84 Est; Lowers FY2026 Sales Guidance from $2.700B-$2.750B t
QuidelOrtho (NASDAQ: QDEL ) lowers FY2026 Adj EPS guidance from $1.80-$2.00 to $0.65-$0.90 vs $1.84 analyst estimate. Lowers FY2026 sales outlook from $2.700 billion-$2.750 billion to $2.520 billion-$2.600 billion vs $2.
EARNINGS | Aug 06, 2026, 08:35 PM UTC
L
JP Morgan Maintains Underweight on QuidelOrtho, Raises Price Target to $12
JP Morgan analyst Casey Woodring maintains QuidelOrtho (NASDAQ: QDEL ) with a Underweight and raises the price target from $11 to $12.
EQUITY | Jul 01, 2026, 02:19 PM UTC